Skip to content

SCENTIA

Active Public limited companyfounded 2001active for 25 yearsRue Saint-Jean 19, 1435 Mont-Saint-GuibertKBO/BCE: BE 0475.668.204

Lifetime

20 annual accounts with figures on one time axis, 24 filings since 2002
peak of €523,482 in 2025
€523,482▲ 8.5%
lowest -€64,225 in 2014
€93,859▲ 0.3%
peak of €576,410 in 2024
€373,269▼ 35.2%
€1.2m▲ 15.8%
peak of 3.9 FTE in 2024
3.9 FTEunchanged
Board2 names since 2013
2 directors and 1 other
Documentsfilings and deeds
01-07-202630 days before the deadline
2025abbreviated format
(managing director) and (managing director) reappointed 23-06Dividend €297,000Equity from €576,410 to €373,269Debts from €1.0m to €1.2m

Key points

from the 2025 annual accounts

Equity

€373,269 ▼ 35.2%
576,4102024+93,859Profit-297,000Dividend373,2692025

SCENTIA paid out €297,000 in dividends. That is 316% of the 2025 profit.

Turnover

≈ €1.8m estimated

The accounts state no turnover.

Debts

€1.2m 76% of the balance sheet
Financial debts 45%Suppliers 15%Taxes and wages 5%Other 35%

Of this, €641,213 falls due within a year.

Staff

5 employees on 31-12-2025
322021222022342024572025

In 2025, 5 employees joined and 7 left.

Filings

24 annual accounts since 2002
AprilJune31 JulyOctober20102020

The last five annual accounts were filed 26 to 30 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,821 companies had the same profile as SCENTIA has now. Each dot stands for 10 companies, two years later.

95.1%
were still trading
3.8%
stopped another way
1.0%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,821 companies, not a prediction for SCENTIA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
Managing director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0475668204
(managing director) and (managing director) reappointed General meeting of 08-05-2025 · Gazette deed
Amendment of the articles General meeting of 12-09-2023 · Gazette deed
Registered office moved within Mont-Saint-Guibert The registered office moved from Grand'Rue 26 à 1435 Mont-Saint-Guibert to Rue Saint Jean 19 C/001 à 1435 Mont-Saint-Guibert · General meeting of 24-08-2020 · Gazette deed
All 40 events

Comparable companies

same main activity, similar in size and age
Company
SCENTIA Mont-Saint-Guibert €1.5m €523,482 24.3% 3.9
PHARMACIE SENEFFE CENTRE Seneffe €1.5m €576,922 39.9% 4
APOTHEEK GYSEMANS Putte €1.5m €499,375 75.9% 3.9
PHARMACIE DU VAL D'ATTERT Attert €1.4m €558,995 54.9% 3.9
PHARMACIE HAMACKER BAILLIEN Liège €1.5m €507,261 53.9% 3.4
MARIACOR Saint-Léger (Lux.) €1.6m €531,054 83.1% 3.6
APOTHEEK DUINEN Bredene €1.6m €574,119 68.9% 3.7

These companies have the same main activity as SCENTIA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.4m and €1.6m, founded between 1997 and 2005.

Official details

Source: KBO
Status
Active since 19-09-2001Normal situation
Registered office
13 active companies are registered at this address2 started in the 12 months before. Source: KBO register, as of 17 November 2026.
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.098.589.6541435 Mont-Saint-Guibert, since 26-11-2001
Financial year end
31 December
Peppol
Reachable since 12-12-2025
Company details

Annual accounts 2025

€1.5m▼ 2.8%
Employeeson 31-12-2025
5▼ 16.7%
Filing
Filed on 01-07-2026, 30 days before the end of the filing period
Financials

Insights on SCENTIA

SCENTIA files the abbreviated format. That format states no turnover. The gross margin rose from €191,465 in 2006 to €523,482 in 2025.

The balance sheet grew most from 2020 to 2022 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SCENTIA

What is the company number of SCENTIA?
The company number of SCENTIA is 0475.668.204. The VAT number is the same number with BE in front: BE 0475.668.204.
Where is SCENTIA based?
The registered office is at Rue Saint-Jean 19, 1435 Mont-Saint-Guibert.Company details
What does SCENTIA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of SCENTIA?
SCENTIA is a public limited company (NV).
When was SCENTIA founded?
SCENTIA was founded on 19-09-2001.
Is SCENTIA still active?
Yes, SCENTIA is an active enterprise in the KBO register.
How many employees does SCENTIA have?
SCENTIA had an average of 3.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does SCENTIA fall under?
In its 2025 annual accounts, SCENTIA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of SCENTIA?
The turnover in financial year 2025 is ≈ €1.8m. This figure is estimated from the gross margin of €523,482 and 42 comparable companies (NACE 477). It probably lies between €1.4m and €2.5m.
Is SCENTIA profitable?
In financial year 2025, SCENTIA made a profit of €93,859.
Where can I find the annual accounts of SCENTIA?
SCENTIA filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SCENTIA due?
SCENTIA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.